IN2012DN00729A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00729A IN2012DN00729A IN729DEN2012A IN2012DN00729A IN 2012DN00729 A IN2012DN00729 A IN 2012DN00729A IN 729DEN2012 A IN729DEN2012 A IN 729DEN2012A IN 2012DN00729 A IN2012DN00729 A IN 2012DN00729A
- Authority
- IN
- India
- Prior art keywords
- modified
- influenza virus
- influenza
- proteins
- introduction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22763809P | 2009-07-22 | 2009-07-22 | |
EP09175096 | 2009-11-05 | ||
PCT/EP2010/060489 WO2011009864A1 (en) | 2009-07-22 | 2010-07-20 | Novel influenza virus |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00729A true IN2012DN00729A (zh) | 2015-06-19 |
Family
ID=41718543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN729DEN2012 IN2012DN00729A (zh) | 2009-07-22 | 2010-07-20 |
Country Status (7)
Country | Link |
---|---|
US (2) | US9771564B2 (zh) |
EP (1) | EP2512508B1 (zh) |
CN (1) | CN102648000A (zh) |
ES (1) | ES2557315T3 (zh) |
HK (1) | HK1177692A1 (zh) |
IN (1) | IN2012DN00729A (zh) |
WO (1) | WO2011009864A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2576773A2 (en) * | 2010-06-02 | 2013-04-10 | Avir Green Hills Biotechnology Research Development Trade AG | Methods and helper viruses for the generation of rna virus |
EP3218470B1 (en) * | 2014-11-13 | 2022-04-06 | Versitech Limited | Live attenuated vaccines for influenza viruses |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1098961T3 (da) | 1998-06-12 | 2008-05-26 | Andrej Y Dr Egorov | Gensplejsede svækkede vira, der inducerer interferon |
PL212316B1 (pl) | 1998-06-12 | 2012-09-28 | Sinai School Medicine | Zastosowania preparatów szczepionek, zastosowania preparatów farmaceutycznych oraz sposoby wytwarzania szczepionek |
EP1911836A1 (en) | 2006-10-12 | 2008-04-16 | AVIR Green Hills Biotechnology Trading GmbH | Medium supplement for virus production |
EP2048237A1 (en) * | 2007-10-05 | 2009-04-15 | Avir Green Hills Biotechnology Research Development Trade Ag | Replication deficient Influenza virus for the expression of heterologous sequences |
US7931906B2 (en) | 2007-09-06 | 2011-04-26 | National Health Research Institutes | Vero cell-based influenza virus strains and vaccines |
EP2233152A1 (en) * | 2009-03-24 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade Ag | High growth reassortant influenza A virus |
-
2010
- 2010-07-20 IN IN729DEN2012 patent/IN2012DN00729A/en unknown
- 2010-07-20 US US13/386,355 patent/US9771564B2/en active Active
- 2010-07-20 WO PCT/EP2010/060489 patent/WO2011009864A1/en active Application Filing
- 2010-07-20 CN CN2010800423400A patent/CN102648000A/zh active Pending
- 2010-07-20 ES ES10734998.7T patent/ES2557315T3/es active Active
- 2010-07-20 EP EP10734998.7A patent/EP2512508B1/en active Active
-
2013
- 2013-04-23 HK HK13104886.4A patent/HK1177692A1/zh unknown
-
2017
- 2017-07-20 US US15/655,306 patent/US20180016560A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US9771564B2 (en) | 2017-09-26 |
WO2011009864A1 (en) | 2011-01-27 |
US20180016560A1 (en) | 2018-01-18 |
EP2512508B1 (en) | 2015-09-02 |
CN102648000A (zh) | 2012-08-22 |
HK1177692A1 (zh) | 2013-08-30 |
ES2557315T3 (es) | 2016-01-25 |
US20120164175A1 (en) | 2012-06-28 |
EP2512508A1 (en) | 2012-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL186611A0 (en) | Vaccine against pandemic strains of influenza viruses | |
CL2012002489A1 (es) | Compuestos derivados de sililo nafto-imidazol; composición farmacéutica; y su uso para prevenir o tratar una infección por el virus de la hepatitis c. | |
MX2021001053A (es) | Vacunas contra virus de la influenza y sus usos. | |
PH12015500347A1 (en) | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
EA025278B9 (ru) | Антивирусная композиция против заключенных или незаключенных в оболочку днк- или рнк-вирусов | |
SG179082A1 (en) | Method for the preparation of an influenza virus | |
EP2217064A4 (en) | NEW VACCINES AGAINST SEVERAL SUBTYPES OF THE INFLUENZAVIRUS | |
IN2014CN02114A (zh) | ||
EP2078083A4 (en) | NEW DOG INFLUENZA VIRUS AND VEGETABLE THEREFOR | |
EA201301320A1 (ru) | 4-арил-n-фенил-1,3,5-триазин-2-амины, которые содержат сульфоксиминную группу | |
WO2011000566A3 (en) | Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections | |
BRPI0913012A2 (pt) | vírus do nilo ocidental/da dengue quiméricos | |
PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
EA201391515A1 (ru) | Инактивированная вакцина вируса денге | |
EA201270361A1 (ru) | Птеридины и их применение в качестве агрохимикатов | |
WO2010147830A3 (en) | Aminothiazole modulators of beta-3-adrenoreceptor | |
EA201290897A1 (ru) | Вакцины для пандемического гриппа | |
CY1114883T1 (el) | Καινοφανεις αντιβακτηριακοι παραγοντες για την αγωγη των κατα gram θετικων λοιμωξεων | |
WO2010095041A3 (en) | Compositions, methods, and kits for treating influenza viral infections | |
JO3281B1 (ar) | مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي | |
HRP20190393T1 (hr) | Pripravak protutijela namijenjen sprječavanju ili liječenju infekcije mutantnim virusom hepatitisa b | |
NZ606087A (en) | Influenza vaccine | |
UY34314A (es) | Derivados de anilina, su preparación y su aplicación terapéutica. | |
PH12015501378A1 (en) | Porcine parvovirus 5a, methods of use and vaccine | |
UY36938A (es) | Nuevos compuestos macrocíclicos modificados |